{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-027465","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2022-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.764117+00:00","generated_at":"2026-06-25T11:41:47.555198+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OptimizeRx authorizes $20M share repurchase program through May 2023","bullets":["Board authorized repurchase of up to $20M of outstanding common stock.","Repurchases may occur in open market or private transactions; program expires May 17, 2023 or when $20M is reached.","Company will finance buybacks using available cash and cash equivalents.","Board may modify, suspend, extend or terminate the program at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-027465","json":"https://secwatch.observer/filing/0001213900-22-027465.json","markdown":"https://secwatch.observer/filing/0001213900-22-027465.md","text":"https://secwatch.observer/filing/0001213900-22-027465.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022027465/0001213900-22-027465-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022027465/ea160087-8k_optimizerx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T11:41:47.555198+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}